Published in Proc Natl Acad Sci U S A on August 18, 1998
Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut (2002) 2.26
Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells. Proc Natl Acad Sci U S A (2000) 1.31
Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity. J Virol (2006) 1.25
CD48-deficient mice have a pronounced defect in CD4(+) T cell activation. Proc Natl Acad Sci U S A (1999) 1.14
CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function. J Exp Med (2004) 1.12
CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance. Blood (2009) 1.04
Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J Exp Med (2003) 0.95
Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells. PLoS One (2013) 0.92
CD4(+)CD25(+) regulatory T cells resist a novel form of CD28- and Fas-dependent p53-induced T cell apoptosis. J Immunol (2009) 0.91
B7-1 mediated costimulation regulates pancreatic autoimmunity. Mol Immunol (2007) 0.86
Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseases. Arthritis Res Ther (2004) 0.84
Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia. PLoS One (2013) 0.83
Associations between CTLA-4 +49 A/G (rs231775) polymorphism and cancer risk: a meta-analysis based on 52 case-control studies. Int J Clin Exp Med (2015) 0.82
Lack of association between cytotoxic T-lymphocyte antigen 4 (CTLA-4) -1722T/C (rs733618) polymorphism and cancer risk: from a case-control study to a meta-analysis. PLoS One (2014) 0.82
What Unrelated Hematopoietic Stem Cell Transplantation in Thalassemia Taught us about Transplant Immunogenetics. Mediterr J Hematol Infect Dis (2016) 0.79
Association between CTLA-4 60G/A and -1661A/G polymorphisms and the risk of cancers: a meta-analysis. PLoS One (2013) 0.79
The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children. Clin Exp Immunol (2006) 0.76
Association between cytotoxic T-lymphocyte antigen-4 +49A/G polymorphism and colorectal cancer risk: a meta-analysis. Int J Clin Exp Med (2015) 0.76
Association between Cytotoxic T-lymphocyte antigen 4 (CTLA-4) +49 G>A (rs231775) polymorphism and esophageal cancer: from a case-control study to a meta-analysis. Int J Clin Exp Med (2015) 0.75
Gene-by-Environment Interactions in Pancreatic Cancer: Implications for Prevention. Yale J Biol Med (2015) 0.75
CTLA-4-Tg/CD-28-KO Mice Exhibit Reduced T Cell Proliferation in vivo Compared to CD-28-KO Mice in a Graft-versus-host Disease Model. Korean J Physiol Pharmacol (2012) 0.75
Cytotoxic T lymphocyte-associated antigen-4 +49A>G polymorphism and the risk of non-small cell lung cancer in a Chinese population. Int J Clin Exp Med (2015) 0.75
Functional diversity of helper T lymphocytes. Nature (1996) 18.09
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science (1995) 16.19
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity (1995) 14.90
CD28/B7 system of T cell costimulation. Annu Rev Immunol (1996) 10.48
CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med (1991) 9.94
CTLA-4 can function as a negative regulator of T cell activation. Immunity (1994) 9.80
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med (1991) 8.78
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med (1995) 8.31
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (1992) 7.15
Differential T cell costimulatory requirements in CD28-deficient mice. Science (1993) 6.93
T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci U S A (1990) 6.19
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med (1996) 6.13
A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J Immunol (1981) 5.85
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell (1995) 5.64
The emerging role of CTLA-4 as an immune attenuator. Immunity (1997) 5.35
CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med (1996) 4.97
Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science (1995) 4.80
Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science (1993) 4.45
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity (1994) 3.73
B70 antigen is a second ligand for CTLA-4 and CD28. Nature (1993) 3.57
Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J Exp Med (1985) 3.48
Identification and distribution of the costimulatory receptor CD28 in the mouse. J Immunol (1992) 3.37
Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J Exp Med (1991) 3.08
B7, a B-cell-restricted antigen that identifies preactivated B cells. J Immunol (1987) 2.92
Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity (1996) 2.08
CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X(L) induction. J Immunol (1998) 2.01
Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med (1993) 1.81
CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci U S A (1995) 1.80
Thymocyte development is normal in CTLA-4-deficient mice. Proc Natl Acad Sci U S A (1997) 1.67
LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci U S A (1997) 1.58
Differential signaling by lymphocyte antigen receptors. Annu Rev Immunol (1997) 1.54
Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med (1996) 1.52
Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med (1995) 1.45
Costimulation of IL-4 production by murine B7-1 and B7-2 molecules. J Immunol (1996) 1.17
BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc Natl Acad Sci U S A (1996) 1.13
Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells. Int Immunol (1995) 1.03
Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc Natl Acad Sci U S A (1997) 0.98
Anti-human class I MHC antibodies induce apoptosis by a pathway that is distinct from the Fas antigen-mediated pathway. J Immunol (1997) 0.96
Increased Fas antigen expression in murine retrovirus-induced immunodeficiency syndrome, MAIDS. Eur J Immunol (1994) 0.82
CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylation. J Immunol (1996) 0.82
Role of protein tyrosine kinases and phosphatases in isotype switching: crosslinking CD45 to CD40 inhibits IgE isotype switching in human B cells. Immunol Lett (1995) 0.81
Construction and properties of new Lyt-congenic strains and anti-Lyt-2.2 and anti-Lyt-3.1 monoclonal antibodies. Immunogenetics (1980) 0.79
Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science (1993) 2.78
Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc Natl Acad Sci U S A (1992) 2.56
CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J Immunol (1992) 1.91
Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med (1993) 1.81
Structural characterization of the TAP molecule: a phosphatidylinositol-linked glycoprotein distinct from the T cell receptor/T3 complex and Thy-1. Cell (1986) 1.77
TAP, a novel T cell-activating protein involved in the stimulation of MHC-restricted T lymphocytes. J Exp Med (1986) 1.49
TAP transcription and phosphatidylinositol linkage mutants are defective in activation through the T cell receptor. Cell (1988) 1.36
Identification of the 2B4 molecule as a counter-receptor for CD48. J Immunol (1998) 1.31
The LY-6 locus: a multigene family encoding phosphatidylinositol-anchored membrane proteins concerned with T-cell activation. Immunol Rev (1989) 1.31
Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. Effect on expression of B7 and B7-2 costimulatory molecules by macrophages. J Immunol (1994) 1.23
Human cytomegalovirus replicates in primary human bone marrow cells. J Gen Virol (1986) 1.18
Costimulation of IL-4 production by murine B7-1 and B7-2 molecules. J Immunol (1996) 1.17
Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation. J Immunol (1992) 1.16
Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J Exp Med (1996) 1.15
Stimulation of T cells via the TAP molecule, a member in a family of activating proteins encoded in the Ly-6 locus. J Immunol (1987) 1.14
CD48-deficient mice have a pronounced defect in CD4(+) T cell activation. Proc Natl Acad Sci U S A (1999) 1.14
Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma. J Clin Invest (1995) 1.11
The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo. J Immunol (1998) 1.09
T cell receptor/CD3 negative variants are unresponsive to stimulation through the Ly-6 encoded molecule, TAP. J Immunol (1988) 1.06
Internalization of phosphatidylinositol-anchored lymphocyte proteins. I. Documentation and potential significance for T cell stimulation. J Immunol (1989) 1.04
The expression, function, and ontogeny of a novel T cell-activating protein, TAP, in the thymus. J Immunol (1986) 1.03
Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor. Proc Natl Acad Sci U S A (1993) 1.03
Gene encoding T-cell-activating protein TAP maps to the Ly-6 locus. Proc Natl Acad Sci U S A (1986) 1.01
IL-4: role in disease and regulation of production. Clin Exp Immunol (1998) 1.00
Effects of cyclosporin A, FK 506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen. Eur J Immunol (1993) 0.95
la-positive T lymphocytes are the producer cells of interferon gamma. Exp Cell Res (1984) 0.93
Activation of CD4+ T lymphocytes form interleukin 2-deficient mice by costimulatory B7 molecules. Proc Natl Acad Sci U S A (1996) 0.86
Enhanced murine CD4+ T cell responses induced by the CD2 ligand CD48. Eur J Immunol (1998) 0.85
Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor. Immunol Res (1998) 0.84
The sgp-60 molecule is linked to the plasma membrane via a glycosylphosphatidylinositol anchor. Eur J Immunol (1991) 0.84
Analysis of mast cells in rheumatoid arthritis and osteoarthritis by an avidin-peroxidase staining. Virchows Arch B Cell Pathol Incl Mol Pathol (1984) 0.83
Retinal oxygen consumption in vitro. The effect of diabetes mellitus, oxygen and glucose. Acta Ophthalmol (Copenh) (1990) 0.82
Identification, by protein sequencing and gene transfection, of sgp-60 as the murine homologue of CD48. Proc Natl Acad Sci U S A (1993) 0.82
Distribution of lysozyme in synovial tissue of patients with osteoarthritis and rheumatoid arthritis demonstrated by different enzyme histochemical methods. Rheumatol Int (1982) 0.82
Linkage analysis of the genetic determinants of T-cell IL-4 secretion, and identification of Flj20274 as a putative candidate gene. Genes Immun (2005) 0.82
Expression of T-cell-activating protein in peripheral lymphocyte subsets. Proc Natl Acad Sci U S A (1986) 0.81
Avidin-peroxidase. A new mast cell staining method. Acta Histochem Suppl (1986) 0.80
Biosynthesis, glycosylation, and partial N-terminal amino acid sequence of the T-cell-activating protein TAP. Proc Natl Acad Sci U S A (1987) 0.80
Modulation of the intracellular Ca2+ and inositol trisphosphate concentrations in murine T lymphocytes by the glycosylphosphatidylinositol-anchored protein sgp-60. J Immunol (1993) 0.80
Expression and function of the costimulatory molecule B7 on murine Langerhans cells: evidence for an alternative CTLA-4 ligand. Eur J Immunol (1994) 0.77
The murine Cd48 gene: allelic polymorphism in the IgV-like region. Eur J Immunogenet (1998) 0.76
Control of Hemorrhage from Wounds of the Coronary Vessels by the Gelatin Sponge Patch Technic: An Experimental Study. Ann Surg (1949) 0.75
Distribution of mast cells in human synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Z Rheumatol (1985) 0.75
T cell-activating protein on murine lymphocytes. Fed Proc (1986) 0.75
[7-fluoro-4-chromone-3-sulfur compounds]. Arch Pharm (Weinheim) (1994) 0.75
[The GOX-anti-GOX(PAP) technic, a new method for the demonstration of adjacent antigens in the same section]. Acta Histochem Suppl (1985) 0.75
[3 new antibody detection tests. A comparative study]. Beitr Infusionsther (1990) 0.75
[Iodine deficiency--clinical consequences and possibilities for prevention]. Med Welt (1983) 0.75